Psychiatry and Neurology, Neurology · Terre Haute, IN
NPI
1871601658
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1739 N 4th St
Terre Haute, IN, 47804
Phone (812) 242-3110
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
1,298 services
Medicare patients, 2024
364
Average age 72
Drug cost, 2024
$2.4M
6,018 prescriptions
Company payments, 2025
$705
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven D Maynard was code 99214 (office e&m - established), 428 times for 279 patients. In total Steven D Maynard billed 1,298 services in 10 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 428 | 279 | $86.57 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 222 | 188 | $11.84 | $2,629 |
| 99213 Office E&M - Established | Office | 164 | 143 | $59.82 | $9,811 |
| 95970 Electrical Nerve Conductivity | Office | 31 | 12 | $12.50 | $388 |
| 95819 Neurologic | Facility | 30 | 30 | $38.95 | $1,169 |
By year: 2022 $56K for 776 services; 2023 $54K for 950 services; 2024 $54K for 1,298 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven D Maynard prescribed most often to Medicare patients was Levetiracetam, with 483 prescriptions and refills. In total Steven D Maynard wrote 6,018 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 483 | 717 | 70 | $16K |
| Donepezil Hcl Generic | 388 | 590 | 67 | $10K |
| Memantine Hcl Er Memantine Hcl | 326 | 525 | 64 | $48K |
| Clopidogrel Clopidogrel Bisulfate | 320 | 733 | 80 | $2,918 |
| Gabapentin Generic | 295 | 447 | 61 | $3,614 |
| Aptiom Eslicarbazepine Acetate | 256 | 281 | 29 | $574K |
| Imipramine Hcl Generic | 254 | 417 | 45 | $6,165 |
| Lacosamide Generic | 229 | 252 | 27 | $40K |
| Memantine Hcl Generic | 188 | 302 | 46 | $4,351 |
| Pregabalin Generic | 183 | 239 | 28 | $7,147 |
| Phenobarbital Generic | 167 | 180 | 20 | $4,538 |
| Tizanidine Hcl Generic | 141 | 210 | 37 | $1,832 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 140 | 201 | 28 | $2,300 |
| Topiramate Generic | 139 | 203 | 18 | $1,439 |
| Oxcarbazepine Generic | 121 | 175 | 17 | $9,518 |
Brand drugs: 906 claims; generic drugs: 4,941 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven D Maynard $705 ($705 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $326.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.